Rhenman & Partners Asset Management AB grew its holdings in shares of Revance Therapeutics, Inc. ( NASDAQ:RVNC – Get Rating ) by 12.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 438,000 shares of the biopharmaceutical company's stock after buying an additional 50,000 shares during the quarter. Rhenman & Partners Asset Management AB owned 0.53% of Revance Therapeutics worth $8,085,000 at the end of the most recent reporting period.

https://www.dailypolitical.com/2023/05/29/rhenman-partners-asset-management-ab-increases-holdings-in-revance-therapeutics-inc-nasdaqrvnc.html

#dailypolitical